Tenax Therapeutics Inc.

(TENX) Trade

By |

Profile

Tenax Therapeutics Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products for critical care patients and its products include Levosimendan and Oxycyte.

Contact Information

Website: www.tenaxthera.com
Email: jesse@sternir.com
Main Phone: +1 919 855-2100
Address: ONE Copley Parkway
Address 2: Suite 490
State: NC
City / Town: Morrisville
Country: USA
Postal Code: 27560

Issuer Information

Exchange: NSC
CEO: Anthony A. DiTonno
Employees: 8
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)(541714)
$ 5.41 $ -0.33 (-5.75%)
Last Price 5.41 Change $ -0.33 Change % -5.75 Tick N/A
Bid 5.03 Bid Size 100.00 Ask 6.44 Ask Size 100.00
Open 5.75 High 5.75 Low 5.38 Prev Close 5.74
Last Trade Volume 6,543 52 Wk Hi 12.63 52 Wk Low 4.41
Market Cap 7.9 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 1,465,496.00 EPS (TTM) -3.79 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 1 6
Number of Buys 1 5
Number of Sells 0 1
Net Activity 6425 6577
Last 10 Buys Shares
Blanck R Ronald 1,000
Blanck R Ronald 1,000
Gerald T. Proehl 1,000
Gerald T. Proehl 1,000
James Mitchum 1,000
James Mitchum 1,000
Blanck R Ronald 1,000
Blanck R Ronald 1,000
Blanck R Ronald 1,000
Anthony A. DiTonno 1,000
Last 10 Sell Shares
Blanck R Ronald 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 41 41 41 41
Low Target Price Estimate 15 15 15 15
Mean Target Price Estimate 28 28 28 28
Standard Deviation 18.38 18.38 18.38 18.38
Date of Most Recent Estimate 06/03/18 05/29/18 04/11/18 06/03/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1